You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

DEXAIMATVNCR

Cancer Type: Hematologic, Leukemia - Acute Lymphoblastic (ALL)      Intent: Curative
Regimen Category: evidence-informed
Funding:
ODB - General Benefit
    dexamethasone
Exceptional Access Program
    iMAtinib - Adults with newly diagnosed Ph+ ALL, with specific criteria

You might also be interested in